About Us
Overview Management Board of Directors Contact Us
Products
Overview LibiGel® Elestrin™ The Pill-Plus™ Bio-T Gel™ CaP
Partners & Licensees
Overview Opportunities
Therapeutic Areas
Female Sexual Dysfunction Menopause Contraception Male Hypogonadism Aesthetic Medicine
Investors
Stock Information Corporate Governance SEC Filings Request Information
Newsroom
News Releases Events Webcasts Media Kit

Improving health for life

BioSante is a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism.


LibiGel® is a transdermal testosterone gel in development for the treatment of female sexual dysfunction (FSD).

05/01/2008 – BioSante Pharmaceuticals to Present at Deutsche Bank Health Care Conference » 04/15/2008 – BioSante Pharmaceuticals Appoints Michael C. Snabes, M.D., PhD, Vice President, Clinical Development »

If you are interested in participating in one of our clinical trials for LibiGel®, please click here for more information.
Copyright © BioSante Pharmaceuticals 2008
Contact Us Site Map NASDAQ:BPAX Legal